Risk factors for theombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies / Nermeen Ahmed Foad ; Supervised Samia Mohammed Hassan Fadda , Ahmed Hamdy Ahmed Mohamed , Sherif Mohammed Gamal
Material type:
- عوامل الخطورة لحدوث التخثر والوقاية الأولية منه فى مرضى الذئبة الحمراء إيجابى وسلبى مضادات الدهون الفسفورية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.32.M.Sc.2010.Ne.R (Browse shelf(Opens below)) | Not for loan | 01010110054487000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.32.M.Sc.2010.Ne.R (Browse shelf(Opens below)) | 54487.CD | Not for loan | 01020110054487000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilitation
Antiphospholipid antibodies (aPL ) namely anticardiolipin antibodies (aCL ) and lupus anticoagulant ( LAC ) have been associated with an increased risk of thrombosis in systemic lupus erythematosus ( SLE ) . We examined additional thrombosis risk factors ( aPL profile , SLE - related and traditional risk factors ) and the primary thrombsis prevention in SLE patients with and without aPL
Issued also as CD
There are no comments on this title.